Biosimilars Market Amplifies from USD 3.35 Billion in 2016 to USD 16.97 Billion by 2023 Registering a CAGR of 26%; Asserts MRFR

0
0
SHARE

Pune, India — (PRESS RELEASE JET) — 10/13/2017 — Executive Summary:

Market Research Future published new report, titled “Biosimilars Market -Research Report: Global Forecast to 2023”.

Market Synopsis of Global Biosimilars Market

Market Scenario:

Biosimilars is a biological medical product which are identical copy of the original medical product. They are not generics nor treated like generic drugs. Biosimilars are derived from bacteria, plant, yeast and many other different process. Increasing incident of different diseases, strategic collaborations resulting in enhanced productivity and clinical trial activities for biosimilars and increasing demand for the cheap medical products is responsible driving the global biosimilars market. On other hand lack of awareness and physician scepticism are the major restraining factor for the growth of the market.

The biosimilars market is expected to reach USD 16.97 Billion by 2023 from USD 3.35 Billion in 2016, at a CAGR of 26 %.

Key Players:

Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Sandoz International GmbH (Germany), Celltrion, Inc. (South Korea), Astra Zeneca (UK), Amgen Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Biocon Ltd. (India), Dr. Reddy’s Laboratories Ltd. (India), Novartis (Switzerland), Accord Healthcare (UK), Eli Lilly (US) and Samsung Bioepis (South Korea).

GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/1329

Market Segments:

Global biosimilars market is segmented on the basis of product into recombinant glycosylated proteins, recombinant non-glycosylated proteins and other. Recombinant glycosylated proteins are further sub segmented into Monoclonal antibody (mAb) and EPO. Recombinant non-glycosylated proteins is sub segmented into insulin, growth hormones and other. On the basis of application the market is segmented into Immune diseases, oncology, blood related disorders and other. On the basis of manufacturing, market is segmented into contract manufacturing and in-house manufacturing.

Regional Analysis:

On regional basis, Europe has dominating market for the biosimilars market. Increasing prevalence of diseases and rising geriatric population has led to grow this market in Europe. North America has second leading market followed by Asia Pacific. Asia Pacific biosimilars market is growing at a CAGR of 27.8 % during 2017-2023.

Study Objectives:

Detailed overview of global biosimilars market.

Detail analysis of global biosimilars market with all possible segmentation and key player of market.

Detailed analysis of the historical and forecasted market on the basis of factors like- price analysis, supply chain analysis, porters five force analysis etc.

To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global biosimilars market.

Detail analysis on the possible segments and sub segments of the market. And regional analysis of the market- North America, Europe, Asia Pacific and Middle East and Africa.

Insights on the major countries/regions in which this industry is flourishing and to also identify the untapped regions which could be the potential markets in future

Market Assessment:

The report for Global Biosimilars Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Intended Audience:

Research and Development (R&D) Companies
Biopharmaceutical drug manufacturers
Biotechnology, biopharmaceutical, and pharmaceutical companies
Medical Research Laboratories
Academic Medical Institutes and Universities
Government and Independent Research Laboratories
Contract Research Organizations (CROs)
Table of Contents

1 Introduction

2 Research Methodology

3 Market Dynamics

4 Market Factor Analysis

5 Global Biosimilars Market, By Product

6 Global Biosimilars Market, By Application

7 Global Biosimilars Market, By Manufacturing

8 Global Pain Management Devices Market, By Region

9 Competitive Landscape

10 Company Profile

11 Conclusion

12 Appendix

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: [email protected]

Powered by WPeMatico